Elanco Animal Health (ELAN) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

Elanco Animal Health

NYSE: ELAN · Real-Time Price · USD
20.64
0.18 (0.86%)
At close: Oct 03, 2025, 3:59 PM
20.68
0.19%
After-hours: Oct 03, 2025, 05:52 PM EDT

Elanco Animal Health Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
4.48B 4.43B 4.44B 4.45B 4.49B 4.37B 4.42B 4.37B 4.33B 4.45B 4.42B 4.54B 4.64B 4.75B 4.76B 4.79B 4.55B 3.86B
Cost of Revenue
2.56B 2.52B 2.53B 2.55B 2.56B 2.5B 2.48B 2.4B 2.38B 2.42B 2.44B 2.51B 2.56B 2.62B 2.69B 2.8B 2.69B 2.36B
Gross Profit
1.93B 1.91B 1.91B 1.9B 1.94B 1.87B 1.94B 1.97B 1.95B 2.02B 1.97B 2.03B 2.09B 2.13B 2.08B 1.99B 1.86B 1.5B
Operating Income
209M 239M 251M 253M 300M 238M 326M 343M 351M 431M 386M 402M 404M 391M 304M 154M 88.4M -12.4M
Interest Income
11M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 100K 100K
Pretax Income
593M 536M 488M 412M -1.24B -1.29B -1.2B -1.16B -103M -38M -71M -102M -188M -410M -565M -764.1M -843.1M -684.2M
Net Income
434M 373M 338M 205M -1.25B -1.3B -1.23B -1.14B -113M -26M -78M -128M -167M -367M -479M -697.8M -728.8M -572M
Selling & General & Admin
1.36B 1.32B 1.31B 1.31B 1.3B 1.29B 1.28B 1.3B 1.28B 1.27B 1.27B 1.29B 1.33B 1.38B 1.4B 1.45B 1.38B 1.16B
Research & Development
354M 351M 344M 342M 341M 333M 327M 328M 320M 321M 321M 333M 349M 361M 369M 389.7M 383.8M 349.2M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
1.72B 1.67B 1.66B 1.65B 1.64B 1.63B 1.61B 1.62B 1.6B 1.59B 1.59B 1.62B 1.68B 1.74B 1.77B 1.84B 1.77B 1.51B
Interest Expense
270M 265M 278M 283M 270M 308M 310M 308M 296M 261M 248M 266M 266M 265M 389M 367.2M 355.3M 313.2M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
4.28B 4.19B 4.19B 4.2B 4.19B 4.13B 4.09B 4.03B 3.98B 4.01B 4.03B 4.14B 4.24B 4.36B 4.46B 4.64B 4.46B 3.87B
Income Tax Expense
159M 163M 150M 207M 11M 11M 36M -12M 10M -12M 7M 26M -21M -43M -86M -66.3M -114.3M -112.2M
Shares Outstanding (Basic)
496.6M 495.1M 494.4M 494.3M 494.2M 493.2M 492.8M 492.7M 492.6M 491.1M 488.5M 488.4M 488.4M 488M 487.4M 487.3M 487.3M 486.7M
Shares Outstanding (Diluted)
500.1M 499.1M 494.4M 497.7M 494.2M 496M 492.8M 492.7M 492.6M 492.8M 488.5M 488.4M 488.4M 492.2M 487.4M 487.3M 487.3M 486.7M
EPS (Basic)
0.89 0.76 0.69 0.41 -2.55 -2.65 -2.5 -2.32 -0.23 -0.05 -0.16 -0.25 -0.33 -0.74 -0.97 -1.43 -1.51 -1.21
EPS (Diluted)
0.87 0.74 0.68 0.40 -2.55 -2.65 -2.5 -2.32 -0.23 -0.05 -0.16 -0.25 -0.33 -0.74 -0.97 -1.43 -1.51 -1.21
EBITDA
1.53B 1.46B 1.43B 1.36B -302M -296M -191M -156M 879M 903M 860M 852M 769M 545M 540M 367.3M 238.7M 266.4M
EBIT
863M 801M 766M 695M -974M -983M -885M -848M 193M 223M 177M 164M 78M -145M -176M -396.9M -487.8M -371M
Depreciation & Amortization
664M 657M 662M 669M 672M 687M 694M 692M 686M 680M 683M 688M 691M 690M 716M 764.2M 726.5M 637.4M